Health tech deals
McDermott Will & Emery has advised Great Point Partners (GPP) on the financing of the acquisition of Cytespace Africa Laboratories by MLM Medical Labs (MLM), a portfolio company of GPP. With this strategic acquisition MLM expands their global footprint into South Africa. MLM Medical Labs headquartered in Mönchengladbach, Germany, with additional laboratories in Memphis, Tennessee, [...]
Stockholm-based biotech firm Epigenica has raised €1.8m to support the development and commercialisation of its gene expression screening technology. The company develops tools to study epigenetics – how environmental and lifestyle factors influence gene activity without altering the DNA sequence – for use in research, diagnostics and drug development. The new investment will also support [...]
LogicFlo today announces a $2.7 million seed funding round to scale its intelligent agent platform across the pharmaceutical, biotech, and medtech industries. The round was led by Lightspeed with participation from leading healthcare and enterprise AI investors. It will fund product expansion, team growth, and deeper deployments with global life sciences organisations, including a Fortune [...]
Berry Fertility has launched Smart Compose, an AI-powered tool designed to help fertility clinic staff draft responses to patient messages while keeping clinicians in control of decision-making. The tool aims to reduce the administrative burden on healthcare professionals by integrating with electronic medical records (EMRs). It pulls relevant chart data, reviews patient queries and message [...]
JEB Technologies and Medovate, two medical device development and commercialisation companies based in East Anglia, have signed a distribution agreement with Murray Medical Solutions Pty Ltd, granting them rights to distribute CamPROBE (The Cambridge Prostate Biopsy Device) across Australia and New Zealand. Professor Vincent Gnanapragasam, a leading urology expert, along with his team at the [...]
Lifeyear, a UK-Estonian healthtech start-up, has raised €2.8 million to launch its remote patient management platform to deliver at-home digital cardiovascular care. With cardiovascular disease (CVD) projected to surge in prevalence and with UK cardiac waiting lists exceeding 418,000 people, the funding marks Lifeyear’s timely entry into the UK market, positioning it to lead the [...]
SuperDial has announced $15 million in new funding to scale its voice AI platform, which automates high-friction insurance calls that cost provider organisations and billing companies billions of dollars every year. The debt and equity series A round was led by SignalFire, with participation from Slow Ventures, Box Group, and Scrub Capital. It includes $3 [...]
Odgers’ Chris Hamilton and Mike Drew examine how high-profile investment is reshaping executive leadership in longevity tech. The longevity tech sector was once a quiet corner of academic research. Now it has rapidly become one of the most exciting frontiers in innovation. Driven by soaring investment from billionaires and mission-led funds, the industry is redefining [...]
McDermott Will & Emery advised Great Point Partners (“GPP”), a Greenwich-based private investment firm focused on the healthcare industry, on the acquisition of a majority stake in Eutecma, a German-based developer of packaging solutions for pharmaceutical cold chain shipments. With this partnership, Eutecma has also acquired Resolvision, Eutecma’s proprietary re-use machine technology utilized at its [...]
Health Tech World explores the latest business developments in the world of health technology. UK announces record investment to rebuild NHS The UK has announced £29bn investment to rebuild the NHS. New investment announced at the Spending Review will enable the NHS to deliver on the government’s Plan for Change to cut waiting lists, improve [...]
